Medical device cybersecurity documentation is the connected set of records that explains what the device can connect to, what could go wrong, which safeguards were chosen, how those safeguards were verified, and how the manufacturer will maintain the product after release. It should help a reviewer and the product team follow one clear chain of reasoning, not hunt through disconnected files.
Documentation often becomes difficult when it is treated as a submission task at the end of development. By then, the architecture may be fixed, security requirements may be spread across teams, and the people who made early decisions may be trying to recall why a control was selected. A stronger approach builds the cybersecurity record as the product takes shape. Each important decision then has a place to live, an owner, and evidence that can be updated when the device changes.
FDA's cybersecurity guidance for medical devices ties the premarket story to design, risk management, and quality-system work. That is useful framing because it keeps the focus on evidence a device team can actually use. This guide outlines the records that most often need to work together, how to make the connections visible, and where teams tend to create avoidable rework.
Start With a Clear System Boundary
A cybersecurity package begins with a plain-language description of the system being assessed. That means more than naming the device. Explain the software, interfaces, accessories, mobile applications, cloud services, hospital or home networks, service tools, manufacturing systems, and data paths that can affect the product's safe or effective use. The description should make it easy to see what is in scope and what is not.
The system boundary matters because security risk is usually created at a connection. A remote service path, wireless link, USB port, update server, external data source, or third-party library can create a path to view information, alter a function, interrupt availability, or complicate recovery. The record should identify who uses each connection, what it is intended to do, what trust assumptions it relies on, and what happens if it fails or becomes unavailable.
Keep the description usable. A diagram can help, but it should be supported by short explanations rather than a dense picture only its creator can interpret. A reviewer should be able to trace a material interface from the architecture to the security requirements, risk assessment, verification plan, and post-market response process. Teams can use Qualira's medical device threat-modeling guide to turn that system map into focused questions about assets, access paths, and consequences.
Document the Security Questions Before Choosing the Controls
The next record is the reasoning that connects the system boundary to real cybersecurity concerns. A useful threat model identifies the assets that need protection, the people or systems that may access them, credible misuse or compromise paths, and the possible effect on confidentiality, integrity, availability, safety, and clinical workflow. It is not a generic catalog of attack names.
Start with concrete questions. Could an unauthorized user change a therapy setting or device configuration? Could delayed or altered data change a clinical decision? Can a lost connection affect an essential function? Could a service account, update package, or connected application be misused? What access, proximity, equipment, credentials, or preconditions would make that scenario realistic? The answers give engineering, quality, clinical, and regulatory teams a common basis for deciding what must be addressed.
The threat model should remain connected to the risk-management record. A technical weakness does not carry the same significance in every device. Its relevance depends on the intended use, user, use environment, access conditions, safeguards already in place, and possible consequence if the device or supporting system does not behave as intended. This connection is what keeps a security assessment from becoming a parallel exercise that never informs product decisions.
Make Requirements and Controls Traceable
Once the team understands the important scenarios, the selected controls need to become clear requirements. A statement such as "the device will be secure" is not useful evidence. A requirement should say what the product must do, the condition it applies to, and the evidence that will show it works. Depending on the device, that may include authenticated access, authorization levels, secure configuration, encrypted communications, audit logging, secure storage, update integrity, recovery behavior, or restrictions on service functions.
Traceability is the discipline that makes this practical. Each material risk or threat scenario should point to one or more controls. Each control should point to a requirement, design decision, and verification activity. When the product changes, the same chain should help the team identify what must be reassessed. A traceability record does not need to be ornate. It needs to make the rationale and evidence easy to follow.
This is also where design controls and cybersecurity become inseparable. A change to an interface, access role, component, cloud dependency, alarm behavior, or update mechanism can alter both the security posture and the evidence needed to support the design. Teams preparing a 510(k) can connect that work to Qualira's 510(k) submission consulting and broader quality system expertise when the security record must align with the larger development and submission plan.
Plan Verification as Evidence, Not a Final Hurdle
Security documentation is only persuasive when it shows how the team verified the controls that matter. Verification should be planned against the requirement and the realistic risk it addresses. For example, a signed-update design may need evidence that invalid packages are rejected, valid updates can be installed through the intended path, interrupted updates do not leave the device unsafe, and the release process preserves the required configuration.
The depth and method will depend on the product. Some controls are best checked through design review, code review, configuration inspection, or test records. Others require focused security testing. NIST's technical guide to security testing and assessment is useful for the basic discipline of planning, conducting, analyzing, and responding to security testing. For a medical device, the result needs to be interpreted in the context of the released configuration and the consequences to the people who rely on the product.
A penetration test, vulnerability scan, or automated tool output is not the complete verification story. Each can supply useful evidence, but the team still needs to determine what was in scope, which version and configuration were tested, which realistic paths were examined, what the findings mean for the device, and how any remediation was verified. Qualira's medical device penetration testing guide explains how to make a test report support those decisions instead of leaving it separate from the product record.
Maintain a Useful Software and Component Inventory
A software bill of materials, or SBOM, is a practical part of cybersecurity documentation because it helps a manufacturer identify software components when a vulnerability is reported. It should be connected to the products and versions that were actually built and released. A component listed without a product version, configuration, or ownership path is much less useful when an urgent assessment is needed.
The SBOM is not a substitute for cybersecurity risk management. It cannot explain whether a vulnerable function is enabled, reachable, or relevant to the device's use environment. It does not identify the controls that limit an attack path or the potential consequence if a weakness is used. Treat it as an inventory that makes investigation faster, then connect it to the device-specific assessment and decision record.
The FDA's cybersecurity FAQs for medical devices explain that applicable premarket submissions for cyber devices must include specified cybersecurity information. Maintaining an accurate component inventory alongside the architecture, threat model, and verification evidence lets the team answer follow-up questions without rebuilding basic product context.
Connect the Premarket Package to the Post-Market Plan
The documentation should also show how the manufacturer will manage cybersecurity after release. A device can remain in service for years while software components, vulnerabilities, connected services, and deployment environments change. A credible lifecycle plan defines how the organization receives vulnerability information, confirms whether a product is affected, assesses the device-specific risk, decides on containment or remediation, verifies a change, and communicates with affected parties when appropriate.
This plan should identify ownership. Product security, software or systems engineering, quality, regulatory, clinical, service, and customer-facing teams may all hold part of the answer. One accountable owner can coordinate the response, but the documentation should show how material decisions move between those functions and where the final rationale is recorded. That is especially important when a decision affects labeling, customer instructions, supplier oversight, a formal change, or a submission commitment.
A well-maintained record avoids the false choice between overreacting to every alert and missing an issue that matters. Qualira's medical device vulnerability management guide gives teams a practical framework for taking in a report, evaluating the actual product, choosing a proportionate response, and preserving the evidence behind that choice.
Use a Review Checklist Before a Major Milestone
Before a submission, design review, major release, or connected-product launch, review the cybersecurity record as one story. Start with the intended use and system boundary. Confirm that the architecture, interfaces, and dependencies are current. Check that the threat model reflects credible scenarios and that material scenarios are connected to risk decisions. Verify that security requirements have defined controls and that the planned or completed testing covers them.
Then look for the usual gaps. Are the software inventory and released configurations aligned? Do verification records state what was tested and what the result means? Does the post-market process name owners and decision points? Do the documents agree about how updates, service access, connectivity loss, and third-party components are handled? If the answers are difficult to locate, the problem is usually not that the team needs more documents. It is that the evidence has not been connected.
Qualira helps medical-device teams make those connections across regulatory strategy, clinical evidence, technical documentation, design controls, quality systems, and lifecycle support. A focused cybersecurity consulting engagement can clarify the decisions that need to be made, identify the evidence that is missing or disconnected, and create a practical path forward before a milestone becomes a delay.
Frequently asked questions
What cybersecurity documentation does FDA expect for a medical device?
The documentation should explain the device's cybersecurity design, its threat-modeling and risk-management approach, the controls selected, the evidence that those controls work, the software components in scope, and the plan for managing cybersecurity after release. The appropriate depth depends on the device, its connectivity, and the risk created by the intended use.
Is a software bill of materials enough for medical device cybersecurity documentation?
No. A software bill of materials helps identify the software components in a product, but it does not explain the device's system boundary, realistic attack paths, patient or clinical consequences, security controls, verification evidence, or response process. It is one useful record in a connected evidence package.
When should cybersecurity documentation be created?
Start when intended use, system boundaries, interfaces, and major architecture decisions are taking shape. The records should then mature with the product. Starting early makes it easier to connect cybersecurity requirements to design controls and verification instead of reconstructing the rationale near a submission deadline.
How often should cybersecurity documentation be updated?
Update it when a change can affect the device boundary, connected services, software components, controls, intended use, deployment environment, or post-market response plan. A useful record stays aligned with the released product and gives the team a reliable basis for future changes or vulnerability assessments.
